PRICES OF WEED LICENSE STATE BY STATE

Your State-by-State Guide to Cannabis Cultivation Business Application and Licensing Fees

Finding out what any particular state is charging prospective cannabis growers to get into the business can be daunting at times.



SUBSCRIBEFebruary 28, 2019

Noelle Skodzinski

Business and finance Compliance Dispensary News Legislation and regulation Medical Cannabis News Trending Stories

Finding out what any particular state is charging prospective cannabis growers to get into the business can be daunting at times. Some states make their fees easy to find and easy to digest. Others can take some time digging through page after page on various websites.


Note, too, that some states are not always accepting any new marijuana cultivation business license applications. Those windows of availability open and close at different times in each state.


With that, here are the cultivation business application and licensing fees for the 33 states that allow medical cannabis and, in some cases, adult-use cannabis businesses. We will update this post as fee structures change in U.S. state-regulated markets; let us know what additional application and licensing information you'd like to see on this post.


RELATED: Interactive Marijuana Legislation Map


Editor's note: This post was originally published in 2015. It was last updated in February 2019.


jim belushi cannabis conference


Alaska


New application fee: $1,000


Standard cultivation facility license: $5,000


Limited cultivation facility license (500 square feet or less): $1,000


Product manufacturing facility license: $1,000


Concentrate manufacturing facility license: $1,000



Arizona


Application fee: $5,000 ($1,000 of which is refundable)


Initial registration fee: $5,000


Annual registration renewal fee: $1,000


In Arizona, medical marijuana nonprofit dispensary licensees are permitted to grow marijuana.



Arkansas


Annual cultivation license fee: $100,000


Performance bond: $500,000



California


Annual license application fees:


Specialty Cottage Outdoor $135


Specialty Cottage Indoor $205


Specialty Cottage Mixed-Light Tier 1 $340


Specialty Cottage Mixed-Light Tier 2 $580


Specialty Outdoor $270


Specialty Indoor $2,170


Specialty Mixed-Light Tier 1 $655


Specialty Mixed-Light Tier 2 $1,125


Small Outdoor $535


Small Indoor $3,935


Small Mixed-Light Tier 1 $1,310


Small Mixed-Light Tier 2 $2,250


Medium Outdoor $1,555


Medium Indoor $8,655


Medium Mixed-Light Tier 1 $2,885


Medium Mixed-Light Tier 2 $4,945


Nursery $520


Processor $1,040


Annual license fees:


Specialty Cottage Outdoor $1,205


Specialty Cottage Indoor $1,830


Specialty Cottage Mixed-Light Tier 1 $3,035


Specialty Cottage Mixed-Light Tier 2 $5,200


Specialty Outdoor $2,410


Specialty Indoor $19,540


Specialty Mixed-Light Tier 1 $5,900


Specialty Mixed-Light Tier 2 $10,120


Small Outdoor $4,820


Small Indoor $35,410


Small Mixed-Light Tier 1 $11,800


Small Mixed-Light Tier 2 $20,235


Medium Outdoor $13,990


Medium Indoor $77,905


Medium Mixed-Light Tier 1 $25,970


Medium Mixed-Light Tier 2 $44,517


Nursery $4,685


Processor $9,370



Colorado


New application fee: $4,000


New application for converting medical cultivation facility to adult-use: $1,750


Annual renewal fee (1,801 to 3,600 plants): $1,100


Annual renewal fee (3,601 to 6,000 plants): $1,800


Annual renewal fee (6,001 to 10,200 plants): $3,300


Annual renewal fee (10,201 to 13,800 plants): $5,300



Connecticut


Initial application fee: $25,000


Cultivation license registration fee: $75,000


Annual cultivation license renewal fee: $75,000



Delaware


Application fee: $5,000


Certification fee: $40,000 (paid every two years)



Florida


Application fee: $60,830


In Florida, medical marijuana treatment centers (MMTCs) are authorized to cultivate, process, transport and dispense medical marijuana. A “supplemental licensing fee” of $174,844 was rescinded in 2018.



Hawaii


Application fee: $5,000


Annual licensing fee: $75,000


In Hawaii, medical marijuana dispensary licensees are permitted to grow, process, transport and dispense marijuana. The state does not offer a cultivation license.



Illinois


Application fee: $25,000


Annual cultivation license fee: $100,000



Louisiana


No cultivation licensing process. Two cannabis companies have successfully placed bids for growing permits awarded to Southern University and Louisiana State University.



Maine


Application fee: $300 per patient (caregiver model)


Annual cultivation license fee: $300 per patient



Maryland


Application fee: $6,000


Annual cultivation license fee: $125,000



Massachusetts





Michigan


State license application fee: $6,000


Class A license fee (500 plants): $150,000


Class B license fee (1,000 plants): $300,000


Class C license fee (1,500 plants): $500,000


Processor license fee: $300,000



Minnesota


Application fee: $20,000


Minnesota requires vertical integration, and has thus far licensed two companies.



Missouri


Cultivation license application fee: $10,000


Missouri began accepting medical marijuana business license applications in January 2019.


Read more about Missouri's medical marijuana industry regulations from Reynolds and Gold here.



Montana


Annual caregiver license fee (up to 10 patients): $1,000


Annual caregiver license fee (11-49 patients): $2,500


Annual caregiver license fee (50 or more patients): $5,000



Nevada


Application fee: $5,000


Annual license fee: $30,000



New Hampshire


Application fee: $3,000


Annual licensing fee: $40,000 or $80,000 (depending on geographic area)


In New Hampshire, alternative treatment centers (ATCs) are authorizing to grow, process and dispense medical marijuana.



New Jersey


Application fee: $20,000 ($18,000 refundable to unsuccessful applicants)


In New Jersey, alternative treatment centers (ATCs) are authorizing to grow, process and dispense medical marijuana. The state has licensed six ATCs as of February 2019.



New Mexico


Application fee: $10,000 ($9,000 refundable to unsuccessful applicants)


Annual license fee: $30,000 for first 150 plants, and $10,000 for each additional 50 plants (up to a 450-plant limit)



New York


Application fee: $10,000


Initial registration fee; $200,000



North Dakota


Application fee: $5,000


Annual licensing fee: $110,000



Ohio


Application fee: $2,000 (up to 3,000 square feet of cultivation area), $20,000 (up to 25,000 square feet of cultivation area)


Initial license fee: $18,000, $180,000


Annual license renewal fee: $20,000, $200,000



Oklahoma


Application fee: $2,500



Oregon


Application fee: $250


Annual licensing fees:


Micro Tier I - $1,000


Micro Tier II $2,000


Tier I $3,750


Tier II $5,750


Medical Canopy: $100



Pennsylvania


Application fee (nonrefundable): $10,000


Application fee (refundable if application is not successful): $200,000


Annual license renewal fee: $10,000


Proof of funds: $2 million, with $500,000 liquid in applicant’s bank account



Rhode Island


Application fee: $5,000


Annual license fee:


Micro-license (up to 2,500 square feet): $5,000


Class A (2,501 to 5,000 square feet): $20,000


Class B (5,001 to 10,000 square feet): $35,000


Class C (10,0001 to 15,000 square feet): $50,000


Class D (15,001 to 20,000 square feet) $80,000




Utah


Application fee: $500



Vermont


No regulated licensing structure.



Washington


Application fee: $250


Annual license fee (Tier 1, 2, 3): $1,480



West Virginia


Application fee: $5,000


Annual license fee: $50,000


Compliance with Legal Cannabis Regulations

Stay up to date on industry news and trends

Enter your email to subscribe to our newsletters.




Arcadia Biosciences Announces New Business Unit Dedicated to Cannabis

With Arcadia Specialty Genomics, the company is dedicating a strategic business unit to the optimization and standardization of cannabis plant content.



SUBSCRIBEFebruary 28, 2019

Press Release

Business and finance News State by State: California Vendor News

DAVIS, Calif.­­(BUSINESS WIRE)­­ Arcadia Biosciences, Inc., an agricultural food ingredient company, today announced the company will apply its expertise to a new crop: cannabis. With the establishment of Arcadia Specialty Genomics™, the company is dedicating a strategic business unit to the optimization and standardization of cannabis plant content, quality, climate resiliency and yield. Arcadia Specialty Genomics intends to conduct its business only in federal and state markets in which its activities are legal.


With a 15­-year track record of agricultural innovation, Arcadia Biosciences has brought new and beneficial crop traits to market through its advanced, proprietary approach to plant breeding and gene editing. With products such as GoodWheat™ flour and SONOVA® GLA safflower, the company develops high­-value food ingredients and nutritional oils that meet consumer demands and improve crop outcomes for farmers. Now, the company will apply its expertise to the burgeoning cannabis industry, with an initial focus on the hemp market.


Chief Financial Officer Matt Plavan has been appointed president of Arcadia Specialty Genomics.


“Within the rapidly growing legal cannabis industry, we see enormous opportunity in – and demand for – improved plant quality, productivity, consistency and resilience,” said Raj Ketkar, president and CEO of Arcadia Biosciences. “With this new operating unit, Arcadia Specialty Genomics, we are uniquely qualified as a proven crop improvement company equipped to address the legacy challenges facing a plant that until recently was largely grown unlawfully.” Ketkar added, “I can think of no one better than Matt Plavan, an industry veteran with a track record of leading transformational market pivots, to lead our new strategic business unit.”


The recent passage of the U.S. Agriculture Improvement Act of 2018 – also known as the Farm Bill – confirmed the federal legalization of hemp, the term given to non­psychoactive cannabis containing less than 0.3% tetrahydrocannabinol (THC). It also included provisions for legalizing on a federal level hemp’s cultivation, transport and sale for the first time in more than 75 years. Hemp, previously considered a Schedule 1 drug and banned as an agricultural crop, lacks substantive plant biology research and suffers from sub-optimal genetics, highly fragmented germplasm and rampant inconsistencies.


According to Plavan, hemp’s newly legal status creates significant market opportunities for a company known for its agronomic excellence. “As we’ve evolved from an agricultural trait provider to a functional ingredient seller, we’ve developed capabilities and partnerships which will drive innovation and growth in hemp­-derived oils such as CBD and other functional plant properties. As with our wheat and soybean products, we will create hemp-­based solutions that allow farmers to be more productive and enable consumer packaged goods companies to differentiate their brands in the marketplace.”


The Hemp Business Journal estimates that the hemp CBD market totaled $190 million in 2018 – an astounding rate of growth for a category that didn’t exist five years ago. By 2022, the Brightfield Group, a cannabis and CBD market research firm, projects sales to reach $22 billion.


Arcadia Specialty Genomics will develop novel cannabis varieties possessing productivity, pest resistance and crop quality traits for license to cultivators, and for products serving the nutraceutical and food industries. These developments are made possible through a proprietary approach combining conventional breeding, Arcadia’s advanced screening and breeding technology known as TILLING and gene editing. Through this process, plant populations carrying desirable, high-­value genetic characteristics are identified, isolated and bred to reproduce.


“Our ability to bring innovative traits to the market for some of the most complex plant genomes is unparalleled, and we’re excited to turn our attention and expertise to the critical needs facing the rapidly evolving cannabis industry,” said Plavan. “Our near­-term focus will be acquiring federal and state licensure in key geographies to launch our research and pilot programs, for which we expect to begin operations in early 2019. In parallel, we are evaluating key partnerships to extend our capabilities vertically, maximize shareholder value and establish Arcadia Specialty Genomics as the leading science-driven company and genetics innovator for cannabis.